428 related articles for article (PubMed ID: 19154823)
1. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
[TBL] [Abstract][Full Text] [Related]
2. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
Mayer NH; Whyte J; Wannstedt G; Ellis CA
Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
4. Spastic cocontraction in hemiparesis: effects of botulinum toxin.
Vinti M; Costantino F; Bayle N; Simpson DM; Weisz DJ; Gracies JM
Muscle Nerve; 2012 Dec; 46(6):926-31. PubMed ID: 23042034
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
Gracies JM; Bayle N; Goldberg S; Simpson DM
Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
Kong KH; Neo JJ; Chua KS
Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
9. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity.
Kawamura A; Campbell K; Lam-Damji S; Fehlings D
Dev Med Child Neurol; 2007 May; 49(5):331-7. PubMed ID: 17489805
[TBL] [Abstract][Full Text] [Related]
11. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
Turkel CC; Bowen B; Liu J; Brin MF
Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
[TBL] [Abstract][Full Text] [Related]
12. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study.
Lai JM; Francisco GE; Willis FB
Adv Ther; 2009 Feb; 26(2):241-8. PubMed ID: 19194671
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
17. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
18. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
[TBL] [Abstract][Full Text] [Related]
19. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
Sobolewski P
Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of dynamic lycra splints on upper limb in hemiplegic patients.
Gracies JM; Marosszeky JE; Renton R; Sandanam J; Gandevia SC; Burke D
Arch Phys Med Rehabil; 2000 Dec; 81(12):1547-55. PubMed ID: 11128888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
